| Oral glucocorticoid–sparing effect of benralizumab in severe asthma P Nair, S Wenzel, KF Rabe, A Bourdin, NL Lugogo, P Kuna, P Barker, ... New England journal of medicine 376 (25), 2448-2458, 2017 | 1019 | 2017 |
| Pulmonary arterial hypertension in patients treated by dasatinib D Montani, E Bergot, S Günther, L Savale, A Bergeron, A Bourdin, ... Circulation 125 (17), 2128-2137, 2012 | 766 | 2012 |
| Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension A Boucly, J Weatherald, L Savale, X Jaïs, V Cottin, G Prevot, F Picard, ... European Respiratory Journal 50 (2), 2017 | 696 | 2017 |
| Tezepelumab in adults and adolescents with severe, uncontrolled asthma A Menzies-Gow, J Corren, A Bourdin, G Chupp, E Israel, ME Wechsler, ... New England Journal of Medicine 384 (19), 1800-1809, 2021 | 646 | 2021 |
| Are overweight asthmatics more difficult to control? P Saint‐Pierre, A Bourdin, P Chanez, JP Daures, P Godard Allergy 61 (1), 79-84, 2006 | 300 | 2006 |
| Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ... The Lancet Respiratory Medicine 7 (1), 46-59, 2019 | 297 | 2019 |
| Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma S Khatri, W Moore, PG Gibson, R Leigh, A Bourdin, J Maspero, M Barros, ... Journal of Allergy and Clinical Immunology 143 (5), 1742-1751. e7, 2019 | 287 | 2019 |
| Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor F Paganin, F Lilienthal, A Bourdin, N Lugagne, F Tixier, R Genin, JL Yvin European Respiratory Journal 24 (5), 779-785, 2004 | 271 | 2004 |
| Systematic literature review of systemic corticosteroid use for asthma management ER Bleecker, AN Menzies-Gow, DB Price, A Bourdin, S Sweet, AL Martin, ... American journal of respiratory and critical care medicine 201 (3), 276-293, 2020 | 255 | 2020 |
| Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis M Kolb, G Raghu, AU Wells, J Behr, L Richeldi, B Schinzel, M Quaresma, ... New England Journal of Medicine 379 (18), 1722-1731, 2018 | 254 | 2018 |
| Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial G Deslée, H Mal, H Dutau, A Bourdin, JM Vergnon, C Pison, R Kessler, ... Jama 315 (2), 175-184, 2016 | 251 | 2016 |
| Integrated care pathways for airway diseases (AIRWAYS-ICPs) J Bousquet, A Addis, I Adcock, I Agache, A Agusti, A Alonso, ... European Respiratory Journal 44 (2), 304-323, 2014 | 216 | 2014 |
| Anti-interleukin-5 therapy in severe asthma G Garcia, C Taillé, P Laveneziana, A Bourdin, P Chanez, M Humbert European Respiratory Review 22 (129), 251-257, 2013 | 213 | 2013 |
| Poor concordance between sequential transbronchial lung cryobiopsy and surgical lung biopsy in the diagnosis of diffuse interstitial lung diseases M Romagnoli, TV Colby, JP Berthet, AS Gamez, JP Mallet, I Serre, ... American journal of respiratory and critical care medicine 199 (10), 1249-1256, 2019 | 186 | 2019 |
| Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort LG Heaney, LP de Llano, M Al-Ahmad, V Backer, J Busby, GW Canonica, ... Chest 160 (3), 814-830, 2021 | 176 | 2021 |
| Specificity of basement membrane thickening in severe asthma A Bourdin, D Neveu, I Vachier, F Paganin, P Godard, P Chanez Journal of Allergy and Clinical Immunology 119 (6), 1367-1374, 2007 | 168 | 2007 |
| Upper airway· 1: Allergic rhinitis and asthma: united disease through epithelial cells A Bourdin, D Gras, I Vachier, P Chanez Thorax 64 (11), 999-1004, 2009 | 165 | 2009 |
| Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial KB Highland, O Distler, M Kuwana, Y Allanore, S Assassi, A Azuma, ... The Lancet Respiratory Medicine 9 (1), 96-106, 2021 | 158 | 2021 |
| Initial dual oral combination therapy in pulmonary arterial hypertension O Sitbon, C Sattler, L Bertoletti, L Savale, V Cottin, X Jaïs, P De Groote, ... European Respiratory Journal 47 (6), 1727-1736, 2016 | 157 | 2016 |
| Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study ME Wechsler, LB Ford, JF Maspero, ID Pavord, A Papi, A Bourdin, H Watz, ... The Lancet Respiratory Medicine 10 (1), 11-25, 2022 | 152 | 2022 |
Isabelle VACHIERCHU Montpellier在 medbiomed.fr 的电子邮件经过验证
